These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15894504)

  • 21. Donor vigilance: what are we doing about it?
    Wiersum-Osselton JC; Marijt-van der Kreek T; de Kort WL
    Biologicals; 2012 May; 40(3):176-9. PubMed ID: 22230318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating the probability of a blood donation adverse event based on 1000 interviewed whole-blood donors.
    Newman BH; Roth AJ
    Transfusion; 2005 Nov; 45(11):1715-21. PubMed ID: 16271095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arm complications after manual whole blood donation and their impact.
    Newman B
    Transfus Med Rev; 2013 Jan; 27(1):44-9. PubMed ID: 22682105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-time whole blood donation: A critical step for donor safety and retention on first three donations.
    Gillet P; Rapaille A; Benoît A; Ceinos M; Bertrand O; de Bouyalsky I; Govaerts B; Lambermont M
    Transfus Clin Biol; 2015; 22(5-6):312-7. PubMed ID: 26476508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case-controlled multicenter study of vasovagal reactions in blood donors: influence of sex, age, donation status, weight, blood pressure, and pulse.
    Trouern-Trend JJ; Cable RG; Badon SJ; Newman BH; Popovsky MA
    Transfusion; 1999 Mar; 39(3):316-20. PubMed ID: 10204597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with fainting: before, during and after whole blood donation.
    Bravo M; Kamel H; Custer B; Tomasulo P
    Vox Sang; 2011 Nov; 101(4):303-12. PubMed ID: 21535440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Indications and Adverse Reactions of Platelet Apheresis.
    Amanat ST; Shakoor HA; Raza M; Khan N; Rauf A
    J Coll Physicians Surg Pak; 2015 Jun; 25(6):403-6. PubMed ID: 26100990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The blood donors' haemovigilance in France].
    Ounnoughene N; Sandid I; Carlier M; Joussemet M; Ferry N
    Transfus Clin Biol; 2013 May; 20(2):182-92. PubMed ID: 23587615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fear of needles and vasovagal reactions among phlebotomy patients.
    Deacon B; Abramowitz J
    J Anxiety Disord; 2006; 20(7):946-60. PubMed ID: 16460906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fear of blood draw and total draw time combine to predict vasovagal reactions among whole blood donors.
    France CR; France JL; Frame-Brown TA; Venable GA; Menitove JE
    Transfusion; 2016 Jan; 56(1):179-85. PubMed ID: 26264764
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An intervention study for the prevention of vasovagal reactions and evaluating donors' experience: Analysis of donors' return for subsequent donation.
    Wiersum-Osselton J; Prinsze F; van den Brekel E; van Dongen A; Hermans F; Bokhorst A; der Kreek TM
    Vox Sang; 2022 Mar; 117(3):313-320. PubMed ID: 34396539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Offering new and returned donors the option to give plasma: implications for donor retention and donor adverse events.
    Thijsen A; Davison TE; Speedy J; Hoad V; Masser B
    Vox Sang; 2021 Mar; 116(3):273-280. PubMed ID: 32702163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nerve affection in connection with bloodletting I. A rare, but potentially serious complication].
    Jepsen JR; Gundolf F
    Ugeskr Laeger; 2001 Jan; 163(2):143-6. PubMed ID: 11379237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood donor haemovigilance in Yaoundé, Cameroon.
    Nchinda EC; Tagny CT; Mbanya D
    Transfus Med; 2012 Aug; 22(4):257-61. PubMed ID: 22630141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rates of vaso-vagal reactions among first time teenaged whole blood, double red cell, and plateletpheresis donors.
    Reiss RF; Harkin R; Lessig M; Mascari J
    Ann Clin Lab Sci; 2009; 39(2):138-43. PubMed ID: 19429799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of immediate adverse effects associated with apheresis donation.
    McLeod BC; Price TH; Owen H; Ciavarella D; Sniecinski I; Randels MJ; Smith JW
    Transfusion; 1998 Oct; 38(10):938-43. PubMed ID: 9767744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres.
    Crocco I; Franchini M; Garozzo G; Gandini AR; Gandini G; Bonomo P; Aprili G
    Blood Transfus; 2009 Jan; 7(1):35-8. PubMed ID: 19290078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasovagal reaction rates and body weight: findings in high- and low-risk populations.
    Newman BH
    Transfusion; 2003 Aug; 43(8):1084-8. PubMed ID: 12869114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How afraid are you of having blood drawn from your arm? A simple fear question predicts vasovagal reactions without causing them among high school donors.
    France CR; France JL; Himawan LK; Stephens KY; Frame-Brown TA; Venable GA; Menitove JE
    Transfusion; 2013 Feb; 53(2):315-21. PubMed ID: 22670781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of RBC apheresis and whole blood donation in allogeneic and autologous blood donors.
    Popovsky MA
    Transfus Apher Sci; 2006 Apr; 34(2):205-11. PubMed ID: 16513425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.